Cairo, Egypt, October 4 2024: Asthavent Inhaler 200 Dose Salbutamol pressurised inhalation BP, indicated for relief of bronchospasm in bronchial asthm
Cairo, Egypt, October 4 2024: Asthavent Inhaler 200 Dose Salbutamol pressurised inhalation BP, indicated for relief of bronchospasm in bronchial asthma of all types, chronic bronchitis and emphysema
Size: 6016px × 4000px
Photo credit: © Tamer Adel / Alamy / Afripics
License: Royalty Free
Model Released: No
Keywords: allergic, allergy, asthma, asthmatic, attack, breath, breathing, bronchial, bronchitis, bronchodilator, care, cfc-free, chemical, cipla, company, congestion, cough, covid-19, disease, drug, editorial, exacerbation, health, illness, illustrative, india, indian, industrial, inhalation, inhale, inhaler, laboratories, limited, medical, medicament, medication, medicine, mouth, multinational, nebulizer, patient, pharmaceutical, pneumonia, prescription, pulmonary, respiratory, salbutamol, spray, therapy, treatment
